Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R

出版年份 2020 全文链接

标题

作者

关键词

GLP-1, Liraglutide, Osteoclast, Osteoclastogenesis, Signalling pathway

出版物

Volume 130, Issue -, Pages 110523

出版商

Elsevier BV

发表日期

2020-07-21

DOI

10.1016/j.biopha.2020.110523

联系作者

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started